I'm not an expert in Pharma, but I would think any company would be happy to have PRO-140 because of it's huge potential. Gilead has the bucks and the CEO has said he is out hunting, so I definitely think that is a possibility, but other big Pharma should easily be able to handle it as well. Who wouldn't want a couple of billion dollars added to your sales every year?!!
That said, nothing is for sure until P3 results are in. There still is risk involved here. Many drugs that looked promising after Phase 2, still have run into problems in Phase 3, so we need to be aware of that possibility.
If it were a sure thing, the stock price would NOT be $1.16. Sure, it is still a small relatively unknown company, but still, the stock price would not be what it is if there were no risk. I'm not betting the farm.
I do think there is little risk between now and the June 20th meeting. We KNOW the results will be good. The price might still fall some between now and then, but after the presentation, it is a pretty sure bet that the price will rise I would think. However, after that, who knows? We have to wait for trial results and hope they are good. There is no reason to think they would not be, but we still do not know. That is why the FDA requires a Phase 3 trial. While we wait, the price could fluctuate a good bit.
With good results, I would think that the stock would be promoted by various agencies, but the jumps might just be temporary. Probably will increase around the time we are expecting final results. There might be a mid=term update as well. I can't remember.
Anyway, I think it is good if we all realize this is still NOT a sure thing.
News 
Market Data 
Discover 
